Abstract:Mei-Yu Lv, Li-Xia Qiang, Bao-Cai Wang, Yue-Peng Zhang, Zhi-Heng Li, Xiang-Shun Li, Ling-Ling Jin, Shou-De Jin Department of Respiratory Medicine, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China Correspondence: Shou-De Jin, Department of Respiratory Medicine, The Fourth Affiliated Hospital of Harbin Medical University, No. 37 Yiyuan Street, Nangang District, Harbin, 150001, People's Republic of China, Tel/Fax +86 0451-85939123, Email Purpose: Pulmonary surfactant proteins A (SP-A) and D (SP-D) are lectins, involved in host defense and regulation of pulmonary inflammatory response. However, studies on the assessment of COPD progress are limited. Patients and Methods: Pulmonary surfactant proteins were obtained from the COPD mouse model induced by cigarette and lipopolysaccharide, and the specimens of peripheral blood and bronchoalveolar lavage (BALF) in COPD populations. H&E staining and RT-PCR were performed to demonstrate the successfully established of the mouse model. The expression of SP-A and SP-D in mice was detected by Western Blot and immunohistochemistry, while the proteins in human samples were measured by ELISA. Pulmonary function test, inflammatory factors (CRP, WBC, NLR, PCT, EOS, PLT), dyspnea index score (mMRC and CAT), length of hospital stay, incidence of complications and ventilator use were collected to assess airway remodeling and progression of COPD. Results: COPD model mice with emphysema and airway wall thickening were more prone to have decreased SP-A, SP-D and increased TNF-α, TGF-β, and NF-kb in lung tissue. In humans, SP-A and SP-D decreased in BALF, but increased in serum. The serum SP-A and SP-D were negatively correlated with FVC, FEV1, FEV1/FVC, and positively correlated with CRP, WBC, NLR, mMRC and CAT scores ( P < 0.05, respectively). The lower the SP-A and SP-D in BALF, the worse the lung function and the increased probability of complications and ventilator use. Moreover, the same trend emerged in COPD patients grouped according to GOLD severity grade (Gold 1– 2 group vs Gold 3– 4 group). The worse the patient's condition, the more pronounced the change. Conclusion: This study suggests that SP-A and SP-D may be related to the progression and prognostic evaluation of COPD in terms of airway remodeling, inflammatory response and clinical symptoms, and emphasizes the necessity of future studies of surfactant protein markers in COPD. Keywords: COPD, pulmonary surfactant protein A and D, airway remodeling Chronic obstructive pulmonary disease (COPD), which has been considered by many scholars for years as a heterogeneous disease caused by multiple factors, is the third leading cause of death in the world and characterized by chronic airway inflammatory infiltration and destruction of normal alveolar structural integrity. 1,2 As the disease progresses, the initiation of inflammatory mechanism and immune system can destroy the structural integrity of the airway and alveolar cells by activating inflammatory cells and promoting the release of a large quantity of cytokines and inflammatory mediators, 3–6 which affects the secretion of pulmonary surfactant proteins (SPs). 7,8 This not only aggravates the formation of emphysema and the progress of COPD but also promotes the occurrence and mortality of inflammatory response in patients with COPD. SPs, which are secreted by alveolar cells and account for 8–10% of pulmonary surfactants, can be divided into four types and named A, B, C, and D according to different structures and molecular weights. In particular, pulmonary surfactant protein A (SP-A) and D (SP-D), which act as defensive guards against airway infection, can activate macrophages and phagocytes by virtue of their hydrophilicity, broad specificity and carbohydrate recognition domain that can bind to microorganisms. Therefore, they could exert the functions of antibacterial and elimination of apoptotic cells, and participate in the process of immune function, inflammatory response and lipid metabolism at the same time. 9 At present, some studies have confirmed that SP-A and SP-D can establish a relationship with COPD in both animal and human studies, but the specific connection and the significance of diagnosis and treatment to the disease in the future are still not clear. Mountains of evidence have proved that the pulmonary emphysema model mice had the following characteristics, such as disorder of phospholipid metabolism on the surface of alveoli, a tendency to decrease SP-A and SP-D expression, and infiltration and aggregation of alveolar macrophages in the airways. These suggested that SP-A and SP-D, which are extremely likely, are involved in the pathogenesis of COPD and have -Abstract Truncated-

Surfaxin attenuates PM2.5-induced airway inflammation via restoring surfactant proteins in rats exposed to cigarette smoke

Zl-n-91, a Selective Phosphodiesterase 4 Inhibitor, Suppresses Inflammatory Response in a COPD-like Rat Model.

Therapeutic Effects of Pulmonary Surfactant on Smoking-Induced Lung Injury in Rats, an Experimental Study

Sirt1 Protects Against Urban Particulate Matter-Induced Airway Inflammation

Preventive and Therapeutic Effects of Suramin on Lipopolysaccharide-Induced Mouse Model of Acute Lung Injury and Its Molecular Mechanism

Surfactant Proteins in Smoking-Related Lung Disease

Prevention of Pulmonary Fibrosis with Salvianolic Acid A by Inducing Fibroblast Cell Cycle Arrest and Promoting Apoptosis

Protective effects of Surfacen® in allergen-induced asthma mice model

[Effects of simvastatin on airway inflammation and airway mucus hypersecretion in rats with chronic obstructive pulmonary disease].

Surfactin attenuates particulate matter-induced COX-2-dependent PGE2 production in human gingival fibroblasts by inhibiting TLR2 and TLR4/MyD88/NADPH oxidase/ROS/PI3K/Akt/NF-κB signaling pathway

Sodium Tanshinone IIA Sulfonate Protects Against Acute Exacerbation of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease in Mice.

Inhalation of Salvianolic Acid B Prevents Fine Particulate Matter-Induced Acute Airway Inflammation and Oxidative Stress by Downregulating the LTR4/MyD88/NLRP3 Pathway

Surfactant Protein D Deficiency Aggravates Cigarette Smoke-Induced Lung Inflammation by Upregulation of Ceramide Synthesis

Effective-component compatibility of Bufei Yishen formula protects COPD rats against PM2.5-induced oxidative stress via miR-155/FOXO3a pathway

Effects of Fengbaisan on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung tissue of rats with chronic obstructive pulmonary disease

Protective Effects of Ferulic Acid on Respiratory Injuries in PM2.5-Induced Asthmatic Rats

Salvianolic acid B inhalation solution enhances antifibrotic and anticoagulant effects in a rat model of pulmonary fibrosis

Tanshinone IIA Sulfonate Protects Against Cigarette Smoke-Induced COPD and Down-Regulation of CFTR in Mice

THE LUNG LEVEL OF CF6 IS REDUCED IN RATS EXPOSURED TO PARTICULATE MATTER

Complex Evaluation of Surfactant Protein A and D as Biomarkers for the Severity of COPD

Hydrogen-rich Saline Inhibits Tobacco Smoke-Induced Chronic Obstructive Pulmonary Disease by Alleviating Airway Inflammation and Mucus Hypersecretion in Rats.